Table 2 Molecular docking analysis of luteolin binding energies with eight core anti-dry AMD targets.

From: Mechanistic analysis of luteolin in mitigating dry age-related macular degeneration through network pharmacology and experimental validation

Gene symbol

Description

PDB ID

Affinity (kcal/mol)

RMSDa

TP53

Tumor Protein P53

1AIE

− 5.9

0.84

TNF

Tumor Necrosis Factor

2R32

− 6.2

0.35

IL6

Interleukin 6

1ALU

− 6.5

0.42

AKT1

AKT Serine/Threonine Kinase 1

1UNQ

− 6.2

0.28

BCL2

BCL2 Apoptosis Regulator

5VAU

− 7.5

0.73

STAT3

Signal Transducer And Activator Of Transcription 3

6NJS

− 7.9

0.49

JUN

Jun Proto-Oncogene

5T01

− 8.9

CASP3

Caspase 3

1NMS

− 8.6

0.59

  1. aThe RMSD was calculated by docking the known ligand to the protein, followed by structural alignment and RMSD computation in PyMOL for comparative analysis.